Loading lessons…
Peptide learning paths
Learn peptides step by step
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
238lessons
8paths
0day streak
0%explored
Start your first lesson
Choose a learning path below or search the library. Progress saves in your browser.
Learning paths
Pick a track — progress rings update as you complete lessons.
5 lessons
7mSafetyIntermediate
MariTide Side Effects: GI Tolerability and Monthly Titration
Monthly conjugates can pack a bigger post-dose GI window. Here's how to think about MariTide tolerability using Phase 2 lessons — without fear content.
7mProtocolsIntermediate
Eloralintide Timing: When to Inject for Best Tolerability
Weekly amylin agonists are not MOTS-c. Here's when to inject eloralintide for tolerability — dose-day meals, evening vs morning, and what to log.
7mSafetyIntermediate
Eloralintide Side Effects: What Phase 2 Tolerability Data Suggests
Amylin agonists can feel GLP-1-like in the gut. Here's how to think about eloralintide tolerability, escalation, and symptom tracking without turning trial data into fear content.
8mResearchAdvanced
BPC-157 and GLP-1 Side Effects: What the Research Really Shows
GLP-1 receptor agonists cause nausea in up to 44% of users and it is the top reason for discontinuation. Here is what the research shows about BPC-157 as a potential gut protectant, and where the evidence stops.
8mPeptidesIntermediate
BRP Peptide: Stanford's AI-Discovered 'Natural Ozempic' Explained
A Stanford AI tool screened 2,600 uncharacterized peptides and identified BRP — a 12-amino acid molecule that cuts food intake by up to 50%, promotes fat burning, and avoids the nausea, constipation, and muscle loss common with GLP-1 drugs. Here's what the research actually shows.
Also available at /blog for legacy links.